BIC targets about 3% organic sales CAGR through 2030 under new outlook
Reuters2026/09/07 17:12- BIC set 2030 targets in its strategic update, projecting about 3% organic net sales CAGR over 2026-2030.
- Adjusted EBIT margin forecast above 15.5% by 2030, supported by productivity and cost-efficiency measures.
- Free cash flow expected above EUR 250 million in 2030; cumulative free cash flow forecast at EUR 900-950 million over 2027-2030.
- Transformation program includes about EUR 100 million targeted opex investment over 2027-2030, front-loaded in 2027-2028; EUR 80 million annualized savings by 2030.
- Capex-to-sales ratio expected around 4% over 2027-2030; dividend payout ratio targeted at 40-50% of adjusted EPS.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector
GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.
Silver Price Forecast: XAG/USD bears have the upper hand below $64.75-$64.85 confluence
Resonac Holdings says RESONAC REPORT 2026 integrated report now available
Japanese Yen edges lower vs USD amid Middle East jitters as Fed, BoJ meetings loom
Crypto prices
More
